Organon & Co. (OGN) Stock

Organon & Co. (OGN) is a Healthcare stock trading at $13.42 (as of 2026-06-18), with a market capitalization of $3.50B and a trailing P/E of 14.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Organon & Co. is a healthcare company that develops and provides health solutions through a portfolio of prescription therapies. Its product areas include women’s health, biosimilars, oncology, cardiovascular, respiratory and allergy medicines, dermatology, bone health, and non-opioid pain management, sold in the United States and internationally.

Valuation — source: SEC EDGAR (first-party)
Price$13.42
Market Cap$3.50B
P/E Ratio14.2
EV / EBITDA15.7
Price / Book3.88
Price / Sales0.57
Dividend Yield0.6%
DCF Value (model)$-2.30
DCF Upside vs Price-117.1%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$6.22B
Net Margin3.0%
Return on Equity27.2%
Debt / Equity9.49
Current Ratio1.97
Revenue Growth (YoY)-3.5%
EPS Growth (YoY)64.7%
FCF Growth (YoY)337.2%
Financial Health — source: SEC EDGAR
Altman Z-Score1.07 (distress)
Piotroski F-Score5/9 (moderate)
Valuation vs Sector & Industry
Stock P/E14.2
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-32.3%
vs Industry-17.8%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($264.69M)
Institutional Holders Tracked10
Congressional Trades (recent)2
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOJoseph T. Morrissey Jr.
Employees10,000
CountryUS
IPO Date2021-05-14

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Perrigo Company plc (PRGO)
  • Stoke Therapeutics, Inc. (STOK)
  • Sionna Therapeutics, Inc. (SION)
  • Syndax Pharmaceuticals, Inc. (SNDX)
  • Harrow Health, Inc. (HROW)
  • Pharvaris N.V. (PHVS)
  • Nurix Therapeutics, Inc. (NRIX)
  • Dianthus Therapeutics, Inc. (DNTH)
OGN earnings history · OGN institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.